Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q2 2024 Earnings Call Transcript August 6, 2024Ligand Pharmaceuticals Incorporated misses on earnings expectations.
Keep Reading →
August 7 - News, Transcripts
Ligand Pharmaceuticals Incorporated beats earnings expectations. Reported EPS is $4.75, expectations were $1.13.
Keep Reading →
May 8 - News, Transcripts
Ligand Pharmaceuticals Incorporated beats earnings expectations. Reported EPS is $1.03, expectations were $0.58.
Keep Reading →
February 28 - News, Transcripts
In this piece, we will take a look at the 13 most promising small-cap stocks according to analysts.
Keep Reading →
December 26 - News, Quantitative Investing
Operator: Thank you for standing by. My name is Danika and I'll be your conference operator today.
Keep Reading →
November 9 - News, Transcripts
Operator: Thank you for standing by. My name is Brian, and I will be your conference operator today.
Keep Reading →
August 10 - News, Transcripts
In this piece, we will take a look at the top 12 small-cap stocks with the highest upside potential.
Keep Reading →
July 29 - Hedge Funds, News
Operator: Thank you for standing by. My name is Kyla Baker and I will be your conference operator today.
Keep Reading →
May 5 - News, Transcripts
Every day, countless stocks see their values rise and fall on the market.
Keep Reading →
May 4 - Hedge Funds, News
Operator: Good evening. My name is Rob and I will be your conference operator today.
Keep Reading →
March 1 - News, Transcripts
Even though the United States stock market is inextricably linked to the US economy, there are increased fears that the factors contributing to the decline of both in the past...
Keep Reading →
November 21 - Hedge Funds, News
Bumbershoot Holdings LP, an investment management firm, published its third-quarter 2021 investor letter – a copy of which can be downloaded here. Bumbershoot Holdings L.P.
Keep Reading →
March 22 - Hedge Fund Investor Letters, News
NEW YORK--(BUSINESS WIRE)-- Fortress Investment Group LLC (“Fortress”) was named the recipient of the inaugural “Diversity and Inclusion Achievement” award at the 2021...
Keep Reading →
November 10 - Hedge Funds, Insider Trading
Wasatch Global Investors, an investment management firm, published its “Wasatch Core Growth Fund” first quarter 2021 investor letter – a copy of which can be downloaded ...
Keep Reading →
May 10 - Hedge Fund Investor Letters, News
We at Insider Monkey have gone over 817 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio...
Keep Reading →
December 18 - Hedge Funds, News
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Keep Reading →
October 6 - Hedge Funds, News
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Keep Reading →
July 12 - Hedge Funds, News
Steve Cohen hasn’t given up on buying the New York Mets.
Keep Reading →
July 10 - Hedge Funds, Insider Trading
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Keep Reading →
June 8 - Hedge Funds, News
We hate to say this but, we told you so.
Keep Reading →
April 8 - Hedge Funds, News
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great...
Keep Reading →
December 20 - Hedge Funds, News
Is Ligand Pharmaceuticals Inc. (NASDAQ:LGND) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research.
Keep Reading →
October 25 - Hedge Funds, News
Hedge fund manager turned cryptocurrency investor Michael Novogratz cautioned that the stock market is nearing the end of its historic rally.
Keep Reading →
August 1 - Hedge Funds, Insider Trading
How do we determine whether Ligand Pharmaceuticals Inc.
Keep Reading →
June 10 - Hedge Funds, News
At Insider Monkey, we pore over the filings of nearly 750 top investment firms every quarter, a process we have now completed for the latest reporting period.
Keep Reading →
April 29 - Hedge Funds, News
Is Ligand Pharmaceuticals Inc.
Keep Reading →
December 12 - Hedge Funds, News
Hedge-fund manager Crispin Odey said underperforming banks are starting to resemble department stores that failed to reinvent themselves quickly enough to compete with online ...
Keep Reading →
August 20 - Hedge Funds, Insider Trading
President Donald Trump's decision Thursday to cancel the Singapore summit with North Korea leader sent the price of gold higher as global investors sought safety.
Keep Reading →
May 24 - Hedge Funds, Insider Trading
Legendary investors such as Leon Cooperman and Seth Klarman earn enormous amounts of money for themselves and their investors by doing in-depth research on small-cap stocks that...
Keep Reading →
December 5 - Hedge Funds, News
The third-quarter stock market correction has turned out to resemble the situation observed during the Asian financial crisis of 1997.
Keep Reading →
November 30 - Hedge Funds, News
David M. Knott’s Dorset Management seems to have had an excellent start to the year.
Keep Reading →
April 17 - Hedge Funds, News
Adam Wright and Gary Kohler’s Blue Clay Capital performed much better than Index Funds in the first quarter, as its 27 long positions in stocks with a market cap above $1.0 ...
Keep Reading →
April 10 - Hedge Funds, News
Carl Wiese founded Grow Partners in 2012. Wiese has more than 22 years of investment management experience.
Keep Reading →
February 20 - Hedge Funds, News
To many of your peers, hedge funds are viewed as useless, old investment tools of an era lost to time.
Keep Reading →
September 11 - News
Now, according to many market players, hedge funds are assumed to be bloated, outdated investment tools of a period lost to current times.
Keep Reading →
September 4 - News
To the average investor, there are tons of gauges investors can use to monitor stocks. A duo of the best are hedge fund and insider trading activity.
Keep Reading →
September 3 - News
If you were to ask many of your fellow readers, hedge funds are seen as useless, old investment tools of a forgotten age.
Keep Reading →
September 3 - News
In the 21st century investor’s toolkit, there are dozens of methods shareholders can use to monitor their holdings.
Keep Reading →
August 27 - News
To many investors, hedge funds are assumed to be overrated, old financial vehicles of an era lost to time.
Keep Reading →
August 25 - News
At the moment, there are dozens of methods investors can use to monitor the equity markets. Some of the most useful are hedge fund and insider trading interest.
Keep Reading →
July 5 - News
It's hard to believe, but 2013 is already more than halfway over. This year has been a good one for many pharmaceutical stocks -- at least so far.
Keep Reading →
July 3 - News
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis...
Keep Reading →
July 1 - News
To most shareholders, hedge funds are perceived as slow, outdated investment vehicles of yesteryear.
Keep Reading →
June 27 - News
If you'd ask most investors, hedge funds are viewed as unimportant, old financial tools of yesteryear.
Keep Reading →
June 10 - News
In the 21st century investor’s toolkit, there are tons of indicators shareholders can use to monitor stocks.
Keep Reading →
June 10 - News
In the 21st century investor’s toolkit, there are dozens of indicators shareholders can use to track Mr. Market.
Keep Reading →
June 6 - News
If you'd ask most investors, hedge funds are seen as slow, old financial tools of yesteryear.
Keep Reading →
April 19 - News